# EBV-TCR-T Cells for EB Virus Infection After HSCT

> **NCT04156217** · PHASE1 · COMPLETED · sponsor: **Hebei Yanda Ludaopei Hospital** · enrollment: 18 (actual)

## Conditions studied

- EBV Emia and EBV Positive PTLD After Allogenic HSCT

## Interventions

- **BIOLOGICAL:** EBV-TCR-T cells

## Key facts

- **NCT ID:** NCT04156217
- **Lead sponsor:** Hebei Yanda Ludaopei Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-10
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-10-31
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2022-03-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04156217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04156217, "EBV-TCR-T Cells for EB Virus Infection After HSCT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04156217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*